RN7SL199P

Across TCGA pan-cancer cohorts, RN7SL199P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RN7SL199P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RN7SL199P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL199P expression acts as an unfavorable survival marker.

ESCA, THYM, and PAAD are the cancer types where RN7SL199P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	All	0.332	0.547	.002	66	view →
THYM	DFS	Tertile	All	0.091	0.884	<.001	36	view →
PAAD	DFS	Tertile	II,III,IV	0.203	0.440	.020	18	view →
DLBC	DFS	Tertile	All	0.022	0.809	<.001	18	view →
THCA	OS	Tertile	II,III,IV	0.586	0.903	.007	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RN7SL199P–ESCA (DFS)

Open the ESCA breakdown →